tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Castle Biosciences expects FY25 revenue to exceed $340M
PremiumThe FlyCastle Biosciences expects FY25 revenue to exceed $340M
1M ago
Castle Biosciences price target raised to $43 from $30 at Guggenheim
Premium
The Fly
Castle Biosciences price target raised to $43 from $30 at Guggenheim
1M ago
Castle Biosciences price target raised to $50 from $37 at Canaccord
Premium
The Fly
Castle Biosciences price target raised to $50 from $37 at Canaccord
2M ago
Castle announces publication of consensus paper on DecisionDx-Melanoma test
PremiumThe FlyCastle announces publication of consensus paper on DecisionDx-Melanoma test
2M ago
Castle Biosciences announces new data on DecisionDx-Melanoma test
Premium
The Fly
Castle Biosciences announces new data on DecisionDx-Melanoma test
3M ago
Castle Biosciences: Strong Financial Performance and Strategic Growth Drive Buy Rating
Premium
Ratings
Castle Biosciences: Strong Financial Performance and Strategic Growth Drive Buy Rating
3M ago
Castle Biosciences Raises Revenue Guidance Amid Strong Q3
PremiumCompany AnnouncementsCastle Biosciences Raises Revenue Guidance Amid Strong Q3
3M ago
Castle Biosciences raises FY25 revenue view to $327M-$335M from $310M-$320M
Premium
The Fly
Castle Biosciences raises FY25 revenue view to $327M-$335M from $310M-$320M
3M ago
Castle Biosciences reports Q3 adjusted EPS (2c), consensus (51c)
Premium
The Fly
Castle Biosciences reports Q3 adjusted EPS (2c), consensus (51c)
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100